Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.66
+1.11%
Mkt Cap $446.57M
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$19.00
Range $19.00 – $19.00
Implied Upside
+119.5%
Consensus $19.00 vs current $8.66
NASDAQ·Healthcare·Biotechnology
$8.66
+1.11%
Mkt Cap $446.57M
No recent rating data.
Price Target (14 analysts)
$19.00
Range $19.00 – $19.00
+119.5%
Consensus $19.00 vs current $8.66